Trimodality therapy in variant urothelial carcinoma: choose wisely
Transl Androl Urol
.
2017 Apr;6(2):322-325.
doi: 10.21037/tau.2017.03.59.
Authors
Panagiotis J Vlachostergios
1
,
Christopher Jakubowski
1
,
Scott T Tagawa
1
2
3
Affiliations
1
Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
2
Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
3
Department of Urology, Weill Cornell Medicine, New York, NY, USA.
PMID:
28540247
PMCID:
PMC5422701
DOI:
10.21037/tau.2017.03.59
No abstract available
Publication types
Editorial
Comment